JP2005518439A5 - - Google Patents

Download PDF

Info

Publication number
JP2005518439A5
JP2005518439A5 JP2003570882A JP2003570882A JP2005518439A5 JP 2005518439 A5 JP2005518439 A5 JP 2005518439A5 JP 2003570882 A JP2003570882 A JP 2003570882A JP 2003570882 A JP2003570882 A JP 2003570882A JP 2005518439 A5 JP2005518439 A5 JP 2005518439A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
hydrogen
migraine
linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003570882A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518439A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/005463 external-priority patent/WO2003072138A1/en
Publication of JP2005518439A publication Critical patent/JP2005518439A/ja
Publication of JP2005518439A5 publication Critical patent/JP2005518439A5/ja
Pending legal-status Critical Current

Links

JP2003570882A 2002-02-26 2003-02-25 抗痙攣性誘導体と抗片頭痛薬を含んで成る片頭痛治療用共治療薬 Pending JP2005518439A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35989402P 2002-02-26 2002-02-26
PCT/US2003/005463 WO2003072138A1 (en) 2002-02-26 2003-02-25 Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents

Publications (2)

Publication Number Publication Date
JP2005518439A JP2005518439A (ja) 2005-06-23
JP2005518439A5 true JP2005518439A5 (cg-RX-API-DMAC7.html) 2006-04-06

Family

ID=27663315

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003570882A Pending JP2005518439A (ja) 2002-02-26 2003-02-25 抗痙攣性誘導体と抗片頭痛薬を含んで成る片頭痛治療用共治療薬

Country Status (18)

Country Link
US (2) US20030225002A1 (cg-RX-API-DMAC7.html)
EP (1) EP1478400A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005518439A (cg-RX-API-DMAC7.html)
KR (1) KR101008326B1 (cg-RX-API-DMAC7.html)
CN (1) CN100352506C (cg-RX-API-DMAC7.html)
AU (1) AU2003213242A1 (cg-RX-API-DMAC7.html)
BR (1) BR0307951A (cg-RX-API-DMAC7.html)
CA (1) CA2419989A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20040846A2 (cg-RX-API-DMAC7.html)
IL (2) IL163720A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04008259A (cg-RX-API-DMAC7.html)
NO (1) NO20043984L (cg-RX-API-DMAC7.html)
NZ (1) NZ534874A (cg-RX-API-DMAC7.html)
PL (1) PL372393A1 (cg-RX-API-DMAC7.html)
RU (1) RU2004126093A (cg-RX-API-DMAC7.html)
UA (1) UA81110C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003072138A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200407729B (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
JP2007523176A (ja) * 2004-02-17 2007-08-16 セプラコア インコーポレーテッド シタロプラム、エスシタロプラム又はシタロプラム代謝物質を用いる片頭痛又は頭痛疾患の治療又は病気の予防法
US20060233892A1 (en) * 2005-04-19 2006-10-19 Curt Hendrix Topiramate compositions for treatment of headache
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
FR2890564B1 (fr) * 2005-09-09 2007-10-19 Servier Lab Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent
WO2007120747A2 (en) * 2006-04-13 2007-10-25 Nupathe Inc. Transdermal methods and systems for the delivery of anti-migraine compounds
EP2023894A4 (en) * 2006-04-25 2010-10-20 Applied Pharma Res FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE
WO2008027557A2 (en) 2006-08-31 2008-03-06 Spherics, Inc. Topiramate compositions and methods of enhancing its bioavailability
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
EP2394643B1 (en) 2006-11-17 2015-09-02 Supernus Pharmaceuticals, Inc. Sustained-release formulations of topiramate
EP2363113B1 (en) * 2006-12-04 2017-08-02 Supernus Pharmaceuticals, Inc. Enhanced immediate release formulations of topiramate
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
BRPI0918623A2 (pt) * 2008-09-17 2015-12-01 Hannover Med Hochschule métodos e kits para tratar distúrbios de cefaleia em grupo
EP2451274B1 (en) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmaceutical compositions
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
WO2018067330A1 (en) * 2016-10-06 2018-04-12 Baylor College Of Medicine Photochromatic modulation with fluorescein for the treatment of photo-oculodynia and blepharospasm
DK3955933T3 (da) * 2019-04-15 2024-02-12 Vistagen Therapeutics Inc Behandling af migræne

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
DE69733081T2 (de) * 1996-08-23 2006-05-11 Endo Pharmaceuticals Inc. (n.d.Ges.d. Staates Delaware) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20020015713A1 (en) * 1996-10-24 2002-02-07 Murdock Robert W. Methods and transdermal compositions for pain relief
EP0957928A1 (fr) * 1997-03-03 1999-11-24 Laboratoires Remilea Compositions d'extraits de plantes, leur procede de preparation, et compositions pharmaceutiques les renfermant
US5855907A (en) * 1997-03-24 1999-01-05 Peyman; Gholam A. Method of treatment of migraine
US5935933A (en) * 1997-07-16 1999-08-10 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating neuropathic pain
US5760007A (en) * 1997-07-16 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating neuropathic pain
GB9720270D0 (en) * 1997-09-25 1997-11-26 Pharmagene Lab Limited Medicaments for the treatment of migraine
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
CN1182845C (zh) * 1999-01-19 2005-01-05 奥索-麦克尼尔药品公司 用于治疗集束性头痛的抗惊厥剂衍生物
EP1210118B1 (en) * 1999-08-20 2004-12-08 Ortho-McNeil Pharmaceutical, Inc. Composition comprising a tramadol material and an anticonvulsant drug

Similar Documents

Publication Publication Date Title
RU2004126093A (ru) Комбинированная терапия для лечения мигрени, включающая применение производных противосудорожных средств и средств от мигрени
AR061584A1 (es) Uso de 2-aminotetralinas sustituidas para la fabricacion de un medicamento para la prevencion, alivio y/o tratamiento de diversos tipos de dolor
CR7510A (es) DERIVADOS DE [1-4] DIAZEPINO[6,7,1-iJ)] QUINOLONA COMO AGENTES ANTIPSICOTICOS Y CONTRA LA OBESIDAD
RU93033485A (ru) Производные индола, фармацевтическая композиция, способ лечения
NO20075623L (no) Benzodioksan- og benzodioksolanderivater og deres anvendelse
JP2002523508A5 (cg-RX-API-DMAC7.html)
JP2012521429A5 (cg-RX-API-DMAC7.html)
NO20055655D0 (no) Anvendelse av azetidinkarboksamidderivater i terapi
NO20062139L (no) Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister
IL166768A (en) 2-oxo-1-pyrrolidine derivatives and a process for their preparation
BR0008979A (pt) Composto quìmico, uso de um composto, método de tratamento, processo de preparação de um composto, composição farmacêutica e método de fabricação da mesma
HUP0302167A2 (hu) Metabotropikus glutamát receptor antagonista hatású kinolinszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
SE0302760D0 (sv) New compounds
DK1697370T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
JP2012521428A5 (cg-RX-API-DMAC7.html)
JP2009523760A5 (cg-RX-API-DMAC7.html)
JP2005512965A5 (cg-RX-API-DMAC7.html)
JP2004529114A5 (cg-RX-API-DMAC7.html)
ATE279192T1 (de) Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung
JP2004510813A5 (cg-RX-API-DMAC7.html)
AU2003269923A8 (en) 2- (phenoxymethyl)- and 2- (phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors
NO20065880L (no) 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor
CA2345406A1 (en) Analgesic
MX2007006081A (es) Tetrahidroisoquinolinas 4-fenil-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina.
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера